Oct. 28, 2012 -- Flu vaccines may do more than guard against infection. New research hints that the vaccine, which is recommended for all adults, may also help the heart.
Two new studies presented at the 2012 Canadian Cardiovascular Congress suggest that heart patients who get flu vaccines have lower risks of heart attacks and strokes and fewer episodes of irregular heart rhythms.
Some cautions apply. Both studies were small and preliminary. Researchers agree that they should be repeated with more people and published in peer-reviewed journals before flu vaccines can be claimed to cut heart risks.
“The current body of evidence makes it difficult for us to know for sure whether influenza vaccination reduces cardiovascular events,” says Jennie Johnstone, MD, an assistant professor in the division of infectious diseases at McMaster University in Toronto, Canada. She was not involved in the research.
Johnstone says the new studies are intriguing but should be followed up.
For the first study, researchers pooled data from four published clinical trials with 3,200 patients that tested flu vaccines against placebo shots. About half the patients in the studies had heart disease. The other half had no history of heart problems.
Patients in the studies were randomly assigned to get fluvaccines or placebos. Over one year, there were 187 major cardiovascular events. Those events included heart-related deaths and non-fatal heart attacks, strokes, emergency heart procedures, hospitalizations for heart failure, or sudden chest pain.
Overall, about 7.8% of the people who didn’t get flu vaccines had a major heart-related event over the course of the next year compared to 4.3% of those who did get flu vaccines, a reduction in risk of almost 50%. Stated another way, researchers estimate that one major heart-related event is prevented for every 34 people who get vaccinated for flu.
“These are very provocative findings. If I could give you a pill that would cut your risk of heart problems in those with either established heart disease or at risk for heart disease in half, I’m pretty sure everybody would be taking that medication,” says researcher Jacob A. Udell, MD, MPH, a clinical investigator at Women’s College Hospital in Toronto, Canada.